Pitavastatin

Chemical formula: C₂₅H₂₄FNO₄  Molecular mass: 421.461 g/mol  PubChem compound: 5282452

Active ingredient description

Pitavastatin competitively inhibits HMG-CoA reductase, the rate-limiting enzyme in the biosynthesis of cholesterol, and inhibits cholesterol synthesis in the liver.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
C10AA08 Pitavastatin C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AA HMG CoA reductase inhibitors
Discover more medicines within C10AA08

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
LIVALO Film-coated tablet FDA, National Drug Code (US) MPI, US: SPL/PLR
LIVAZO Film-coated tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 147511-69-1
DrugBank Drug: DB08860
KEGG Drug: D01862
PubChem Compound: 5282452
RxNorm Ingredient: 861634
SNOMED-CT Concept: 443586000
Pitavastatin (substance)
UNII Identifier: M5681Q5F9P
PITAVASTATIN

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.